Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Theravance Biopharma

Clinical trials sponsored by Theravance Biopharma, explained in plain language.

Theravance Biopharma TBPH NASDAQ

A biopharmaceutical company focused on respiratory and infectious disease treatments.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New pill aims to stop dangerous blood pressure drops in rare brain disease

Symptom relief Ongoing

This phase 3 study tests a drug called ampreloxetine for people with multiple system atrophy (MSA) who experience dizziness and fainting due to low blood pressure when standing. About 102 adults with MSA will take the drug for 20 weeks, then some will switch to placebo to see if …

Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief

Last updated Jun 26, 2026 13:24 UTC